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Abstract
Background: Age and life expectancy of residents in many developed countries, including Australia, is increasing.
Health resource and medicine use in the very old is not well studied. The purpose of this study was to identify
annual use of health services and medicines by very old Australian veterans; those aged 95 to 99 years (near
centenarians) and those aged 100 years and over (centenarians).
Methods: The study population included veterans eligible for all health services subsidised by the Department of
Veterans’ Affairs (DVA) aged 95 years and over at August 1
st 2006. A cohort of veterans aged 65 to 74 years was
identified for comparison. Data were sourced from DVA claims databases. We identified all claims between August
1
st 2006 and July 31
st 2007 for medical consultations, pathology, diagnostic imaging and allied health services,
hospital admissions, number of prescriptions and unique medicines. Chi squared tests were used to compare the
proportion of centenarians (those aged 100 years and over) and near centenarians (those aged 95 to 99 years)
who accessed medicines and health services with the 65 to 74 year age group. For those who accessed health
services during follow up, Poisson regression was used to compare differences in the number of times
centenarians and near centenarians accessed each health service compared to 65 to 74 year olds.
Results: A similar proportion (98%) of centenarians and near centenarians compared to those aged 65 to 74
consulted a GP and received prescription medicine during follow up. A lower proportion of centenarians and near
centenarians had claims for specialist visits (36% and 57% respectively), hospitalisation (19% and 24%), dental (12%
and 18%), physiotherapy (13% and 15%), pathology(68% and 78%) and diagnostic imaging services (51% and 68%)
(p < 0.0001) and a higher proportion had claims for care plans (19% and 25%), occupational therapy (15% and
17%) and podiatry services (54% and 58%) (p < 0.0001). Compared to those aged 65 to 74, a lower proportion of
centenarians and near centenarians received antihypertensives, lipid lowering therapy, antiinflammatories, and
antidepressants (p < 0.0001) and a higher proportion received antibiotics, analgesics, diuretics, laxatives, and anti-
anaemics (p < 0.0001).
Conclusions: Medical consultations and medicines are the health services most frequently accessed by Australian
veteran centenarians and near centenarians. For most health services, the proportion of very old people who
access them is similar to or less than younger elderly. Our results support the findings of other studies which
suggest that longevity is not necessarily associated with excessive health service use.
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T h ea v e r a g ea g ea n dl i f ee x p e c t a n c yo ft h eA u s t r a l i a n
population is increasing. In the 1970s life expectancy for
males was around 68 years and 75 years for females; by
the 2000s this had increased to 78 years for men and 83
years for women [1]. The proportion of the Australian
population aged over 65 years increased from 11% in
1988 to 13% in 2008 [2]. This is largely due to a rise in
the number of people aged 85 years and over. Over the
20 years between June 1988 and June 2008 the propor-
tion of the Australian population aged 85 years and over
rose by 165%; while the overall size of the Australian
population increased by only 29% during this time [2].
T h en u m b e ro fp e o p l ea g e d9 5t o9 9y e a r s( n e a rc e n t e -
narians), and the number of centenarians (those aged
100 years and over) nearly tripled in this 20 year period
[2]. The health of Australian centenarians and near cen-
tenarians has not been widely studied.
International studies have reported the mean number
of comorbidities amongst centenarians ranges from two
to four [3-6]. Comorbidities associated with mortality
and morbidity amongst the elderly, including heart dis-
ease, stroke and diabetes, are less prevalent amongst
centenarians and tend to be diagnosed after age 80
amongst centenarians who suffer them [5-8].
The proportion of centenarians using prescription
medicines ranges from 54% to 95% [3,9,10]. Types of
medicines commonly used by this age group are drugs
for hypertension and cardiovascular and gastrointestinal
conditions [3,9-11]. Health resource use by centenarians
and near centenarians is not widely reported. A study of
Greek centenarians found that 79% had visited their
general practitioner (GP) in the past year[12] and a
study of Danish centenarians found that 42% contacted
their GP in the previous three months [3]. Nearly all
centenarians have been hospitalised at least once in
their lifetime [3,12]. A 2003 analysis by age group of
health service use by Australian veterans found that
amongst the 95 years and older age group 94% saw
their GP during the year of follow-up [13]. A smaller
proportion of this age group (62%) saw specialists, and
just over half (52%) aged 95 years and over were hospi-
talised [13]. Medicine use by those aged 95 and over
was common, with 89% having prescription medicines
dispensed [13]. However, centenarians and near cente-
narians as two distinct age groups were not studied.
Australians have access to free treatment at public
hospitals and free or subsidised treatment by GPs and
some allied health professionals under Medicare, funded
by the Australian government [14]. Access to medicines
is subsidised under the Pharmaceutical Benefits Scheme
(PBS) and Repatriation Pharmaceutical Benefits Scheme
(RPBS) [14]. Patients pay a co-payment for medicines
with the remainder of the cost met by the Australian
government [14]. Older people tend to use more medi-
cines than younger people, and the contribution of an
ageing population to increased government expenditure
on medicines subsidy has been acknowledged [15]. The
potential for the ageing population to lead to an
increase in demand for Medicare funded health services,
and the associated increase in government funding costs
has also been discussed [16,17]. However, the influence
of the rapidly growing number of centenarians and near
centenarians on increased medicine and health resource
use in Australia has had limited study and the available
studies have not considered centenarians as a distinct
age group. This is an important area for research,
because population projections suggest that centenarians
will number 13,000 by 2020,[18] compared to 6,000 in
2010. In this study, we aimed to identify the annual use
of health services and medicines by Australian veteran
centenarians (those aged 100 years and over) and near
centenarians (those aged 95 to 99 years).
Methods
Data for this study were sourced from the Department
of Veterans’ Affairs (DVA) health claims databases. The
DVA treatment population is comprised mainly of
Australian defence force veterans and their eligible
dependants, including spouses, widows or widowers, and
children. Over two thirds of the DVA treatment popula-
tion have served in the Australian defence force, with
89% of those who served being male [19]. Reflecting
this, in 2009 59% of the overall DVA treatment popula-
tion were male and over 70% were aged 70 years or
over [20]. Eligible veterans who hold a DVA gold card
receive all health services and medicines subsidised by
DVA [19]. White card holders receive DVA subsidy for
health services and medicines for the treatment of speci-
fic service related conditions only [19]. The DVA claims
databases contain details of all prescription medicines,
medical and allied health services and hospitalisations
provided to veterans for which DVA pay a subsidy. The
data file contains 80 million pharmacy records, 200 mil-
lion medical and allied health service records and over 6
million hospital records for a treatment population of
310,000 veterans. DVA maintain a client file, which
includes data on gender, date of birth and date of death.
Subjects for this study were DVA gold card holders,
eligible for all DVA funded health services, who were 96
years of age or older on August 1
st 2007. We retrospec-
tively extracted data on all claims in the year prior
(August 1
st 2006 to July 31
st 2007) for the following
health services: general practice consultations, specialist
consultations, care planning services (including GP care
plans, discharge plans and multidisciplinary case confer-
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allied health services (including occupational therapist,
speech therapist, dietician, physiotherapy, social work
and podiatrist services), dental consultations, psycholo-
gist services and hospital admissions. In addition, we
extracted counts of the number of prescriptions and
unique medicines (defined by ATC code) dispensed.
The proportion of subjects accessing each health service
and the proportion of subjects dispensed each class of
medicine, defined by the third digit ATC code, was
assessed. Amongst those who accessed health services,
the mean number of times each service was accessed
was determined.
Sub-group analysis was undertaken by age group: near
centenarians (those aged 95 to 99 years) and centenar-
ians (those aged 100 years and over). This age group
definition allowed focus on Australian centenarians, an
age group for which little prior research has been con-
ducted [21]. The influence of the increasing number of
centenarians and near centenarians medicine and health
resource use in Australia has had limited study. There-
fore, to enable comparison of health service use by cen-
tenarians and near centenarians with health service use
by younger elderly people, a comparison cohort of DVA
gold card holders aged 65 to 74 years was identified in
an identical manner. This age group was chosen because
more than half of all Australians aged 65 years and over
are aged between 65 and 74 years.
Chi squared tests were used to compare the propor-
tion of centenarians and near centenarians who
accessed medicines and health services with the 65 to
74 year age group. For those who accessed health ser-
vices during follow up, Poisson regression was used to
compare differences in the mean number of times cen-
tenarians and near centenarians accessed each health
s e r v i c ec o m p a r e dt o6 5t o7 4y e a ro l d s .N oc o v a r i a t e s
were included in the Poisson regression. Post hoc pair
wise comparisons were undertaken to compare the
three age groups, with no adjustments made for multi-
ple comparisons. All analyses were undertaken using
SAS, V9.1 (SAS institute, Cary, North Carolina, USA).
Ethics approval for the study was obtained from the
Department of Veterans’ Affairs Human Research Ethics
Committee and the University of South Australia
Human Research Ethics Committee.
Results
The study population consisted of 1,734 veterans aged
95 years and over. The majority (n = 1,624, 93.6% of the
very old cohort) were aged between 95 and 99 years
(near centenarians), while 110 (6.3%) were aged 100
years or more (centenarians). Two thirds of near cente-
narians (n = 1,100, 67.7%) were female, while 82% of
centenarians (n = 90) were female. Just under half of
near centenarians (n = 800, 49%) and 67% of centenar-
ians (n = 74) lived in residential care during the study
period.
The proportion of centenarians and near centenarians
who consulted a GP and had a prescription medicine
dispensed during the year of follow up was similar to
t h o s ea g e d6 5t o7 4y e a r s ,9 8 %( t a b l e1 ) .Al o w e rp r o -
portion of centenarians and near centenarians consulted
a specialist (36% and 57% respectively, table 1).
Compared to the 65 to 74 year age group, a lower
proportion of centenarians had claims for hospitalisation
(19% vs. 33%), dental services (12% vs. 43% ), phy-
siotherapy services (13% vs. 25%), pathology (68%vs.
83%) and diagnostic imaging services (51%vs. 77%) dur-
ing the study period. A higher proportion of centenar-
ians compared to those aged 65 to 74 years accessed
health care plans (19% vs. 3%), case conferences (4% vs.
0.9%), occupational therapy (15% vs. 8%) and podiatry
services (54% vs. 37%) (table 1).
Compared to the 65 to 74 year age group, a lower
proportion of near centenarians had claims for hospitali-
sation (24% vs. 33%), dental services (18% vs. 43%), phy-
siotherapy services (15% vs. 25%), pathology (78% vs.
83%) and diagnostic imaging services (68% vs. 77%) dur-
ing the study period. A higher proportion of near cente-
narians compared to the 65 to 74 year age group
accessed health care plans (25% vs. 3%), case confer-
ences (4% vs. 0.9%), occupational therapy (17% vs. 8%)
and podiatry services (58% vs. 37%) (table 1).
For the proportion of near centenarians who accessed
at least one service, they tended to have more GP and
specialist visits, received more prescriptions and unique
medicines and had more physiotherapy visits than those
aged 65 to 74 who accessed these services (table 2).
For the proportion of centenarians who claimed at
least one service, they had a higher number of GP and
physiotherapy visits than those aged 65 to 74 who
accessed these services (table 3). For all other health ser-
vices studied, the number of times centenarians accessed
them was no different to those aged 65 to 74 (table 3).
Compared to those aged 65 to 74, a lower proportion
of centenarians had claims for medicines acting on the
renin-angiotensin system (26% vs. 51%), lipid lowering
therapy (3% vs. 49%), calcium channel blockers (15% vs.
24%), beta blockers (11% vs. 23%), antiinflammatories
(10% vs. 32%), psychoanaleptics (12% vs. 27%), systemic
corticosteroids (5% vs. 13%), antihistamines (2% vs. 11%)
and medicines for airways disease (13% vs. 25%), gout
(6% vs. 11%) and diabetes (4% vs. 14%)(table 4). Com-
pared to those aged 65 to 74, centenarians had a higher
proportion with at least one claim for antibiotics
(66% vs. 56%), analgesics (67% vs. 47%), psycholeptics
(42% vs. 32%), eye preparations (57% vs. 30%), diuretics
(56% vs. 18%), laxatives (34% vs. 11%), cardiac therapy
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anti-anaemics (20% vs. 7%) (table 4).
Compared to those aged 65 to 74, a lower proportion
of near centenarians had claims for medicines acting on
the renin-angiotensin system (41% vs. 51%), lipid lower-
ing therapy (11% vs. 49%), antiinflammatories (14% vs.
32%), antihistamines (7% vs. 11%) and medicines for air-
ways disease (17% vs. 25%) and diabetes (4% vs. 14%)
(table 4). Compared to those aged 65 to 74, near cente-
narians had a higher proportion with at least one claim
for antibiotics (66% vs. 56%), analgesics (64% vs. 47%),
antithrombotics (48% vs. 38%), cardiac therapy (34% vs.
Table 1 Number of subjects with at least one claim for service between August 1
st 2006 and July 31
st 2007
Service type Veterans aged
65-74 years
n = 20,413
Near centenarians
(95-99 years)
n = 1,624
Centenarians
(≥ 100 years)
n = 110
Chi square*
GP visit 19,872 (97.3%) 1,590 (97.9%) 108 (98.2%) 2.1071; p = 0.35
Specialist visit 14,848 (72.7%) 917 (56.5%) 40 (36.4%) 261.2; p < 0.0001
Health care plan 583 (2.9%) 412 (25.4%) 21 (19.1%) 1795.1; p < 0.0001
GP plan 3,062 (15.0%) 205 (12.6%) 10 (9.1%) 9.6; p = 0.008
Case conference 174 (0.85%) 60 (3.7%) 4 (3.6%) 121.1; p < 0.0001
Pathology 16,985 (83.2%) 1,260 (77.6%) 75 (68.2%) 49.6; p < 0.0001
Diagnostic imaging 15,782 (77.3%) 1,097 (67.5%) 56 (50.9%) 119.8; p < 0.0001
Occupational therapy 1,686 (8.3%) 271 (16.7%) 16 (14.5%) 136.0; p < 0.0001
Speech therapy 46 (0.2%) 9 (0.6%) 0 6.8; p = 0.0327
Dietician 551 (2.7%) 17 (1.0%) 2 (1.8%) 16.6; p = 0.0002
Dental 8,697 (42.6%) 291 (17.9%) 13 (11.8%) 418.1; p < 0.0001
Physiotherapy 5,037 (24.7%) 236 (14.5%) 14 (12.7%) 92.7; p < 0.0001
Social work 27 (0.1%) 2 (0.1%) 0 0.2; p = 0.9257
Psychologist 248 (1.2%) 3 (0.2%) 0 15.5; p = 0.0004
Podiatry 7,563 (37.0%) 947 (58.3%) 59 (53.6%) 297.1; p < 0.0001
Hospital admission 6,795 (33.3%) 388 (23.9%) 21 (19.1%) 69.6; p < 0.0001
Prescription 19,778 (96.9%) 1,590 (97.9%) 108 (98.2%) 5.8; p = 0.054
*df = 2 for all comparisons
Table 2 Mean (95% confidence interval) number of times 65-74 year olds and 95-99 year olds accessed each medical
and allied health service
Service type Veterans aged
65-74 years
Near centenarians
(95-99 years)
Rate ratio
(95% CI)*
(Near centenarians compared to 65-74 years)
GP visit 10.80 (10.69,10.92) 14.82 (14.36,15.30) 1.37 (1.33, 1.42) p < 0.0001
Specialist visit 6.25 (6.14, 6.37) 8.31 (7.79, 8.86) 1.33 (1.24, 1.42) p < 0.0001
Health care plan 1.01 (1.00, 1.01) 1.02 (1.02, 1.03) 1.02 (1.01, 1.03) p < 0.0001
GP plan 1.85 (1.81, 1.88) 1.55 (1.43, 1.67) 0.84 (0.77, 0.91) p < 0.0001
Case conference 1.34 (1.27, 1.43) 1.20 (1.08, 1.34) 0.89 (0.79, 1.01) p = 0.0741
Pathology 15.78 (15.50,16.06) 16.37 (15.36,17.44) 1.04 (0.97, 1.11) p = 0.2746
Diagnostic imaging 7.68 (7.53, 7.83) 7.60 (7.05, 8.19) 0.99 (0.92, 1.07) p = 0.7906
Occupational therapy 2.51 (2.42, 2.61) 2.79 (2.56, 3.05) 1.11 (1.01, 1.22) p = 0.0310
Dietician 3.97 (3.69, 4.26) 3.18 (2.02, 4.99) 0.80 (0.51, 1.26) p = 0.3406
Dental 1.53 (1.52, 1.55) 1.41 (1.33, 1.49) 0.92 (0.87, 0.97) p = 0.0024
Physiotherapy 14.86 (14.43,15.29) 22.64 (20.32,25.23) 1.52 (1.36, 1.70) p < 0.0001
Podiatry 5.82 (5.76, 5.89) 5.55 (5.37, 5.74) 0.95 (0.92, 0.99) p = 0.0073
Hospital admission 2.26 (2.20, 2.32) 1.80 (1.59, 2.05) 0.80 (0.70, 0.91) p = 0.0007
Number of prescriptions 50.70 (50.21,51.20) 55.18 (53.40,57.02) 1.09 (1.05, 1.13) p < 0.0001
Number of unique medicines 11.53 (11.43,11.64) 12.65 (12.27,13.03) 1.10 (1.06, 1.13) p < 0.0001
*Calculated using Poisson regression.
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vs. 30%), diuretics (42% vs. 18%), laxatives (40% vs. 11%),
mineral supplements (18% vs. 7%), medicines for bone
disease (15% vs. 9%) and anti-anaemics (15% vs. 7%)
(table 4).
Discussion
Our study characterised health resource and medicine
use by Australian centenarians and near centanarians.
We found that, while use is frequent with 98% accessing
GP services and using prescription medicines, for most
health services studied the proportion of centenarians
and near centenarians who accessed them was similar to
or less than the proportion of veterans aged 65 to 74
who accessed them. Amongst centenarians and near
centenarians who accessed one or more health service,
in most cases they did so a similar number of times in
comparison to younger people.
The need to know more about the health status of
Australian centenarians to inform health and public pol-
icy development has been highlighted [21]. Recent stu-
dies provide evidence to support the notion that
longevity is not necessarily associated with excessive
health resource use and costs. An American study
found that although overall health expenditure increased
with age, this was largely due to increased use of nur-
sing homes by the elderly [22]. They found that within
the elderly population, the rate of acute health care use
and expenditure decreased with increasing age [22]. An
Australian study found similar results. Using Medicare
claims data, they found that high health service usage
and costs were associated with death, but not increasing
age [23]. This finding has also been reflected in British
[24,25] and New Zealand[26] studies. Our findings pro-
vide further evidence that suggests, in comparison to
younger elderly people, Australians centenarians and
near centenarians are not excessive users of health
services.
Our study highlighted that the health service most
commonly accessed by centenarians and near centenar-
ians was GP visits; accessed by 98% of near centenarians
and centenarians during the study period. This was
slightly higher than the rate of GP visits by centenarians
in other countries; with a study of Greek centenarians
finding that 79% had visited their GP in the previous
year [12], and a Danish study finding that 42% of cente-
narians had visited their GP in the previous three
months [3]. Use of other health services by centenarians
and near centenarians has not been extensively reported
previously. A study of Danish centenarians showed the
mean number of hospitalisations per person per three
years at the ages 97 to 99 was 1.45[3], equivalent to 0.48
hospitalisations per person per year; while a study of
centenarians in the USA found a mean of 0.6 hospital
admissions per centenarian per year [4]. Our study
reported results slightly differently and showed that,
amongst those hospitalised, the mean number of admis-
sions during the year was 1.5 and 1.8 amongst centenar-
ians and near centenarians respectively. Expression of
our results in a comparable way to the prior research
Table 3 Mean (95% confidence interval) number of times 65-74 year olds and ≥ 100 year olds accessed each medical
and allied health service
Service type Veterans aged
65-74 years
Centenarians
(≥ 100 years)
Rate ratio
(95% CI)*
(Centenarians compared to 65-74 years)
GP visit 10.80 (10.69,10.92) 15.26 (13.54,17.19) 1.41 (1.25, 1.59) p < 0.0001
Specialist visit 6.25 (6.14, 6.37) 7.48 (5.39,10.37) 1.20 ( 0.86, 1.66) p = 0.2860
Health care plan 1.01 (1.00, 1.01) 1.00 (0.97, 1.03) 0.99 (0.97, 1.03) p = 0.7376
GP plan 1.85 (1.81, 1.88) 1.50 (1.04, 2.16) 0.81 (0.56, 1.17) p = 0.2619
Case conference 1.34 (1.27, 1.43) 1.25 (0.83, 1.89) 0.93 (0.61, 1.41) p = 0.7326
Pathology 15.78 (15.50,16.06) 11.68 (8.58,15.89) 0.74 (0.54, 1.01) p = 0.0559
Diagnostic imaging 7.68 (7.53, 7.83) 6.75 (4.75, 9.59) 0.88 (0.62, 1.25) p = 0.4735
Occupational therapy 2.51 (2.42, 2.61) 2.19 (1.45, 3.30) 0.87 (0.58, 1.31) p = 0.5073
Dietician 3.97 (3.69, 4.26) 1.00 (0.10,10.40) 0.25 (0.02, 2.63) p = 0.2492
Dental 1.53 (1.52, 1.55) 1.23 (0.93, 1.63) 0.80 (0.61, 1.06) p = 0.1249
Physiotherapy 14.86 (14.43,15.29) 24.93 (16.33,38.06) 1.68 (1.10, 2.56) p = 0.0167
Podiatry 5.82 (5.76, 5.89) 5.71 (5.01, 6.51) 0.98 (0.86, 1.12) p = 0.7729
Hospital admission 2.26 (2.20, 2.32) 1.52 (0.84, 2.75) 0.67 (0.37, 1.22) p = 0.1923
Number of prescriptions 50.70 (50.21,51.20) 47.36 (41.35,54.25) 0.93 (0.82, 1.07) p = 0.3261
Number of unique medicines 11.53 (11.43,11.64) 11.06 (9.77,12.51) 0.96 (0.85, 1.09) p = 0.5041
*Calculated using Poisson regression
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centenarian per year and 0.43 hospitalisations per near
centenarian per year; comparable to the rate of hospita-
lisation amongst Danish near centenarians and lower
than the rate of hospitalisation amongst American
centenarians.
Use of medicines is the most common health activity
undertaken by Australians,[27] and our results show
that centenarians and near centenarians use multiple
medicines at similar levels to their younger elderly
counterparts. However, the types of medicine used differ
greatly. For example, 3% of centenarians received lipid
lowering medicines compared to 49% of those aged 65
to 74. Calcium channel blockers and beta blockers were
dispensed to 15% and 11% of centenarians, compared to
24% and 23% of those aged 65 to 74. This may reflect
lower prevalence of chronic conditions in centenarians
for which these medicines are used to treat, or conver-
sely, it may reflect under-treatment of chronic
conditions in centenarians. There is evidence of lower
prevalence of hypertension amongst centenarians,[6,28]
and studies of Italian and Japanese centenarians have
demonstrated low total cholesterol in this age group
[28]. Prevalence of diabetes amongst centenarians is also
low in some studies [6,8]. However, other studies have
suggested that there is under treatment of chronic con-
ditions in the very old, [23,29-32] in some cases due to
under diagnosis [33]. Diagnoses are not included in the
DVA dataset, so we were unable to determine whether
our results indicate differing prevalence of chronic dis-
eases by age group or under-treatment in centenarians.
Centenarians and near centenarians are rarely
included in randomised controlled trials, meaning that
data regarding the safety and efficacy of medicines in
centenarians and near centenarians is limited. One
study found that out of more than 50,000 randomised
controlled trials published between 1990 and 2002, only
84 focussed on people aged 80 years and over, and the
Table 4 Number of subjects dispensed each medicine class* between August 1
st 2006 and July 31
st 2007
Medicine group
(ATC code)
Veterans aged
65-74 years
n = 20,413
Near centenarians
(95-99 years)
n = 1,624
Centenarians
(≥ 100 years)
n = 110
Chi square**
Antibacterial for systemic use (J01) 11,346 (55.6%) 1,066 (65.6%) 73 (66.4%) 66.4; p < 0.0001
Analgesics (N02) 9,642 (47.2%) 1,042 (64.2%) 74 (67.3%) 188.0; p < 0.0001
Agents acting on renin-angiotensin system (C09) 10,497 (51.4%) 670 (41.3%) 29 (26.4%) 88.1; p < 0.0001
Antithrombotic agents (B01) 7,659 (37.5%) 786 (48.4%) 42 (38.2%) 75.3; p < 0.0001
Drugs for acid related disorders (A02) 9,209 (45.1%) 732 (45.1%) 45 (40.9%) 0.78; p = 0.68
Ophthalmologicals (S01) 6,189 (30.3%) 852 (52.5%) 63 (57.3%) 370.8; p < 0.0001
Serum lipid reducing agents (C10) 10,024 (49.1%) 173 (10.7%) 3 (2.7%) 978.9; p < 0.0001
Psycholeptics (N05) 6,488 (31.8%) 704 (43.3%) 46 (41.8%) 95.7; p < 0.0001
Corticosteroids for dermatological use (D07) 5,348 (26.2%) 447 (27.5%) 26 (23.6%) 1.8; p = 0.41
Diuretics (C03) 3,627 (17.8%) 687 (42.3%) 61 (55.5%) 660.1; p < 0.0001
Calcium channel blockers (C08) 4,950 (24.2%) 334 (20.6%) 16 (14.5%) 16.6; p = 0.0003
Beta blocking agents (C07) 4,660 (22.8%) 318 (19.6%) 12 (10.9%) 17.6; p < 0.0001
Psychoanaleptics (N06) 5,475 (26.8%) 368 (22.7%) 13 (11.8%) 25.5; p < 0.0001
Cardiac therapy (C01) 2,931 (14.4%) 550 (33.9%) 39 (35.5%) 459.9; p < 0.0001
Anti-inflammatory agents (M01) 6,563 (32.2%) 223 (13.7%) 11 (10.0%) 262.2; p < 0.0001
Drugs for obstructive airways disease (R03) 5,050 (24.7%) 268 (16.5%) 14 (12.7%) 63.6; p < 0.0001
Laxatives (A06) 2,226 (10.9%) 643 (39.6%) 37 (33.6%) 1126.9;p < 0.0001
Drugs for treatment of bone diseases (M05) 1,866 (9.1%) 246 (15.1%) 9 (8.2%) 62.9; p < 0.0001
Corticosteroids for systemic use (H02) 2,653 (13.0%) 161 (9.9%) 5 (4.5%) 19.5; p < 0.0001
Mineral supplements (A12) 1,499 (7.3%) 291 (17.9%) 25 (22.7%) 254.6; p < 0.0001
Antianaemic preparations (B03) 1,507 (7.4%) 247 (15.2%) 22 (20.0%) 146.4; p < 0.0001
Otologicals (S02) 2,012 (9.9%) 244 (15.0%) 11 (10.0%) 43.7; p < 0.0001
Antigout preparations (M04) 2,175 (10.7%) 137 (8.4%) 6 (5.5%) 10.9; p = 0.004
Drugs used in diabetes (A10) 2,917 (14.3%) 72 (4.4%) 4 (3.6%) 134.3; p < 0.0001
Antihistamines for systemic use (R06) 2,268 (11.1%) 109 (6.7%) 2 (1.8%) 39.5; p < 0.0001
*Data for medicine groups dispensed to ≤10% of all veterans not shown
**df = 2 for all comparisons
Roughead et al. BMC Geriatrics 2010, 10:83
http://www.biomedcentral.com/1471-2318/10/83
Page 6 of 8mean age of patients included in these studies was 83
years [34]. Safety of drug therapy in centenarians and
near centenarians is of particular concern due to the
increased risk of adverse drug reactions associated with
increasing age [35]. Efficacy of drug therapy in centenar-
ians and near centenarians is also an important consid-
eration. It has been suggested that GPs may be less
willing to prescribe medicines for the very old in the
absence of efficacy data [36], particularly given the
increased risk of adverse effects in this population[37].
Results of our study have highlighted that nearly all cen-
tenarians and near centenarians use medicines so it is
important that future research focuses on the safety and
efficacy of medicines in this age group.
Our study is limited by lack of information on the
actual health conditions and comorbidities suffered by
centenarians and near centenarians. It is possible that
low use of some health resources in our study reflects
the inability to access required services. It has been sug-
gested that lower rates of hospitalisation amongst very
old people may not reflect better health, but rather the
preference of families and doctors to care for the very
old in the home [26,38]. We were unable to determine
whether this influenced results of our study.
Although we reported the mean number of unique
medicines dispensed to centenarians and near centenar-
ians, and the proportion dispensed each class of medi-
cine; we did not describe persistence with drug therapy
or differences in doses used by centenarians and near
centenarians in comparison to other elderly people. This
limitation has also been evident in prior studies of cen-
tenarians, which have described the proportion of cente-
narians using medicine by drug class, but not dosage or
duration of therapy [3,9,10]. This is an important con-
sideration and should be the focus of future research,
because safe doses of medicine may be lower and appro-
priate duration of therapy may differ between centenar-
ians, near centenarians and younger patients.
Although our cohort was limited to veterans, results
are likely to be applicable to other elderly Australians.
Age specific comparisons of DVA gold card holders with
the wider Australian population have shown that DVA
gold card holders with no service related disability have a
similar number of GP visits (rate ratio 0.99, p > 0.5) and
slightly fewer hospitalisations (rate ratio 0.97, p < 0.05)
per year compared to other elderly Australians [39]. The
likelihood of receiving a prescription at a GP visit is simi-
lar for the DVA population and the wider Australian
population [39]. Our results are likely to be applicable to
other Australian centenarians and near centenarians.
Conclusion
Our study characterised health service and medicine use
amongst Australian veteran centenarians and near
centenarians. Compared to those aged 65 to 74, a simi-
lar or lower proportion of centenarians and near cente-
narians accessed the health services studied, and those
who accessed services did so a similar number of times
in comparison to the younger age group. Our results
support the findings of other studies which suggest that
longevity is not necessarily associated with excessive
health service use.
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